The Covid pandemic accelerated the development of cancer vaccine

The Covid pandemic gave a major boost to the vaccine field. The Danish biotech company Expres2ion Biotechnologies, which is developing a vaccine against breast ...

Pilots want to live too

Borreliavaccin försenas efter strul med studie

Pfizers och Valnevas borreliavaccin, som kan bli det första i sitt slag, försenas med åtminstone ett år. Orsaken är problem vid prövningssajter i USA som tvinga...

Mercodia AB

Utmanar Car-T

Svenska Biolamina ska utveckla metoder för tillverkning av NK-celler. "Orsakar inte någon immunreaktion".

A new international stem cell research centre has been created in Copenhagen

A new centre for stem cell research opened to the public in January. The Novo Nordisk Foundation backs the initiative with the ambition that the centre will advance new medical technology and ...

Novo Nordisk buys drug candidate in billion dollar deal

The Danish pharmaceutical giant Novo Nordisk have made an agreement with KBP Biosciences to aqcuire the hypertension drug ocedurenone for up to 1.3 billion doll...

Vaccinpartners på väg att bli rivaler

Franska Valneva och danska Bavarian Nordic, två partners som distribuerat och marknadsfört varandras produkter sedan 2020, kommer snart att bli rivaler inom vac...

Improve Productivity and Accessibility with Award-winning Human-Centered Design

Enhance your workflow with integrated intelligence.

Anna Törner: Success requires bold decisions!

“Doing things right is fine, but doing the right things as soon as possible is even better”, writes Anna Törner in a column.

Danska läkemedelsfonder investerar i talangfabrik

Novo Nordisk Foundation, Lundbeck Foundation och Leo Foundation investerar 123 miljoner danska kronor, motsvarande omkring 188 miljoner svenska kronor, i ett ny...

Did you know that not every sphere is really a round sphere?

ZEISS Metrology Expert Tip.

"Unclear proposal from the EU Commission on how to solve the MDR challenges"

Even before the EU regulation on medical devices (MDR) came into force, medical technology companies and doctors were concerned that it would endanger the avail...

FOKUS Patient turns international

FOKUS Patient is arranging conferences over 3 days in October, and this year, the focus will be on international collaborations.

Helena Strigård: The rise of the community

Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.

Dansk aktör köper krisande amerikanskt cancerbolag

Danska Pharmacosmos tar över det amerikanska läkemedelsbolaget G1 Therapeutics i en affär som uppgår till 405 miljoner dollar.

Nya genterapin Breyanzi får klartecken av EMA

CAR-T-terapin Breyanzi mot olika typer av Hodgkins lymfom rekommenderas av den europeiska läkemedelsmyndigheten EMA för marknadsgodkännande. Det är den femte CAR-T-behandlingen som får tummen upp i EU....

ZEISS Insights: Measurement of bone plates and screws

Get free access to technical paper.

Cytel Inc acquires the SDS Group

The multinational statistical software developer and contract research organization Cytel Inc, headquartered in Massachusetts, USA, acquires the Swedish consult...

Microscope and measuring machine in one

ZEISS O-INSPECT duo covers two essential applications in quality assurance.

Opinion: Where do all the cool Swedish life science companies go?

It’s puzzling why Swedish life science companies hardly get a mention alongside Spotify, Skype, Klarna, King, iZettle, and other cool, innovative and successful...

Swedish life science in political focus

It feels like 2017 will be a good year for Swedish life science, says Anders Blanck, CEO at LIF.

Anocca tar in 400 miljoner – ska ta första produkterna till klinisk prövning

Cellterapibolaget Anocca tar in 400 miljoner i en nyemission som ska bidra till att ta bolagets första cancerbehandlingar till klinisk prövning.

“We need to keep investing in research and innovation”

that the ambitions will be strong going forward”, says Jenni Nordborg.